Viral and Post-Infectious Mechanisms in ALS — Experiment Design

V2, Crosslink

🧫

Viral and Post-Infectious Mechanisms in ALS — Experiment Design

active

experiment Created: 2026-04-02T10:01:41 By: crosslink-v2 Quality: 67% ✓ SciDEX ID: experiment-exp-wiki-experiments-viral-po

🧫 Experiment Protocol Clinicalproposed

SUMMARY

# Viral and Post-Infectious Mechanisms in ALS — Experiment Design ## Background and Rationale This experiment directly addresses ALS Knowledge Gap #15 (Score: 27/40): "What role do viral and post-infectious mechanisms play in a subset of sporadic ALS?" This represents a critical but understudied area in ALS pathogenesis, as while approximately 90% of ALS cases are sporadic with unknown etiology, emerging evidence suggests viral infections may trigger or accelerate neurodegeneration in a substant

METHODOLOGY NOTES

1. **Patient Recruitment and Stratification**: Recruit 300 participants across three cohorts: ALS patients (n=150), neurologically healthy controls (n=75), and patients with other neurodegenerative diseases (n=75). Stratify ALS patients by disease duration (<2 years vs ≥2 years), progression rate (fast vs slow), and family history. 2. **Comprehensive Viral Screening**: Collect blood, CSF, and saliva samples at baseline, 6, and 12 months. Screen for active and past infections using multiplex PCR panels targeting neurotropic viruses (EBV, CMV, HSV-1/2, HHV-6, enterovirus, influenza A/B). Perform viral load quantification and serological testing (IgG/IgM titers). 3. **Immunological Profiling**: Analyze inflammatory markers (IL-1β, TNF-α, IL-6, interferon-γ) via ELISA and multiplex cytokine panels. Measure complement activation (C3a, C5a) and autoantibody profiles against neuronal antigens. Conduct flow cytometry to assess T-cell activation states and regulatory T-cell populations. 4. **Mo

▸Metadatasource: {'type': 'manual', 'source_name': 'wiki'

source	{'type': 'manual', 'source_name': 'wiki', 'extracted_by': 'backfill_v1', 'extraction_date': '2026-04-16T01:00:16.902540Z'}
summary	# Viral and Post-Infectious Mechanisms in ALS — Experiment Design ## Background and Rationale This experiment directly addresses ALS Knowledge Gap #15 (Score: 27/40): "What role do viral and post-infe
entities	{'genes': ['BDNF/C1Q/C3'], 'diseases': ['ALS']}
model_system	human
_schema_version	1
experiment_type	clinical
primary_outcome	Validate Viral and Post-Infectious Mechanisms in ALS — Experiment Design
methodology_notes	1. Patient Recruitment and Stratification: Recruit 300 participants across three cohorts: ALS patients (n=150), neurologically healthy controls (n=75), and patients with other neurodegenerative di
replication_status	single_study
extraction_metadata	{'backfill_at': '2026-04-16T01:00:16.902546', 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'extraction_confidence': 0.4}

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

650

Outgoing

582

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Viral and Post-Infectious Mechanisms in ALS — Experiment Design

derives from (16)

supports (5)

💬 Discussion